Clinical Trials

507 enrolled 65 charts 2 FDA

Gastrointestinal

Adenocarcinoma, Neoplasms, Stomach Neoplasms

NCT06088290 2026-04-17

SaLuDo

450 enrolled

Sarcoma

Leiomyosarcoma, Neoplasms

NCT04421963 2026-04-16

ROSY-O

185 enrolled

BreastGynecologic

Breast Neoplasms, Neoplasms, Ovarian Neoplasms

NCT07100730 2026-04-16

IPAX BrIGHT

50 enrolled

CNS

Brain Neoplasms, Glioblastoma, Neoplasm Recurrence, Local, Neoplasms, Central Nervous System Neoplasms

NCT07504458 2026-04-16

QUATRO-APL

Other hematologic neoplasm

150 enrolled

Hematologic Diseases, Leukemia, Neoplasms, Leukemia, Promyelocytic, Acute, Hematologic Neoplasms

NCT04464226 2026-04-15

Study to Continue Treatment With Darolutamide in Patients Who Have Been Participating in Previous Darolutamide Studies Supported by Bayer

402 enrolled

Neoplasms

NCT04928846 2026-04-14

A Study to Assess Disease Activity and Adverse Events of Intravenous (IV) Telisotuzumab Vedotin Compared to IV Docetaxel in Adult Participants With Previously Treated Non-Squamous Non-Small Cell Lung Cancer (NSCLC)

698 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung, Neoplasms

NCT03148418 2026-04-13

A Study in Participants Previously Enrolled in a Genentech- and/or F. Hoffmann-La Roche Ltd-Sponsored Atezolizumab Study (IMbrella A)

382 enrolled

Neoplasms

NCT03555422 2026-04-13

ENGOT-EN5

263 enrolled

Gynecologic

Genital Diseases, Neoplasms, Neoplasms by Site, Uterine Diseases, Uterine Neoplasms, Endometrial Neoplasms

NCT05377554 2026-04-13

Bevonescein for Intra-Operative Nerve Visualization in Head and Neck Surgery

154 enrolled

Neoplasms

NCT05862285 2026-04-13

UmbrellaMAX

100 enrolled

Neoplasms

NCT06191744 2026-04-13

EPCORE™FL-2

1,095 enrolled

Lymphoid

Lymphoma, Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Neoplasms

NCT06496971 2026-04-09

A Prospective Pivotal Study to Evaluate the Efficacy and Safety of Avastin® Bevacizumab (BEV) With or Without Microbubble-mediated Focused Ultrasound (FUS-MB) Using NaviFUS System in Recurrent Glioblastoma Multiforme Patients

32 enrolled

CNS

Brain Neoplasms, Glioblastoma, Glioma, Neoplasms, Neoplasms, Nerve Tissue

NCT07410117 2026-04-09

ROXI-CAT-I

860 enrolled

Classical hematology

Hemorrhage, Neoplasms, Pulmonary Embolism, Venous Thrombosis, Venous Thromboembolism

NCT06072612 2026-04-07

BRIA-ABC

404 enrolled

Breast

Breast Neoplasms, Neoplasm Metastasis, Neoplasms

NCT05112965 2026-04-06

An Extension Study in Participants Previously Enrolled in a Genentech and/or F. Hoffmann-La Roche Ltd Sponsored Atezolizumab Study (IMbrella C)

49 enrolled

Neoplasms

NCT05629234 2026-04-06

ROSY-T

37 enrolled

Neoplasms

NCT06867705 2026-04-03

RC-102

1,458 enrolled

Neoplasms

NCT06901531 2026-04-03

LUCERNA

500 enrolled

Adenocarcinoma, Neoplasms

NCT06252649 2026-04-02

CodeBreaK 301

450 enrolled

Gastrointestinal

Neoplasms, Colorectal Neoplasms

NCT04529772 2026-03-31

ESCALADE

611 enrolled

Lymphoid

Lymphatic Diseases, Lymphoma, Lymphoma, Non-Hodgkin, Lymphoproliferative Disorders, Neoplasms, Lymphoma, B-Cell, Lymphoma, Large B-Cell, Diffuse

NCT06135415 2026-03-25

TirbAKare

DermatologicOther neoplasm

280 enrolled

Keratosis, Neoplasms, Precancerous Conditions, Keratosis, Actinic

NCT07493304 2026-03-25

ROXI-CAT-II

Phase 3 Not yet recruiting

1,600 enrolled

Classical hematology

Neoplasms, Pulmonary Embolism, Venous Thrombosis, Venous Thromboembolism

NCT04472598 2026-03-23

TRANSFORM-1

252 enrolled 17 charts

Myeloid

Neoplasms, Primary Myelofibrosis

NCT03844048 2026-03-20

An Extension Study of Venetoclax for Subjects Who Have Completed a Prior Venetoclax Clinical Trial

LymphoidOther hematologic neoplasmPlasma cell

165 enrolled

Lymphoma, Non-Hodgkin, Multiple Myeloma, Neoplasms, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Myeloid, Acute, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT07480356 2026-03-18

ADVANCED-3

Phase 3 Not yet recruiting

284 enrolled

Non-Muscle Invasive Bladder Neoplasms, Urinary Bladder Neoplasms, Carcinoma in Situ, Neoplasms

NCT07313891 2026-03-17

BOOST

Phase 3 Withdrawn

Non-Muscle Invasive Bladder Neoplasms, Urinary Bladder Neoplasms, Neoplasms, Urologic Neoplasms

NCT07342517 2026-03-17

RESCUE

Phase 3 Withdrawn

Phase 3 Not yet recruiting

Neoplasms, Urologic Neoplasms

NCT07464145 2026-03-11

RESCUE

393 enrolled

Non-Muscle Invasive Bladder Neoplasms, Urinary Bladder Neoplasms, Neoplasms, Urologic Neoplasms

NCT06691984 2026-03-06

Phase 3 Study of Xaluritamig vs Cabazitaxel or Second Androgen Receptor-Directed Therapy in Participants With Progressive Metastatic Castration-Resistant Prostate Cancer (XALute)

675 enrolled